The Role of MicroRNA in Hepatitis C Virus Replication
Xiao-Qiong Duan, Shi-Lin Li, Yu-Jia Li, Bing Liu, Pei-Bing Zeng, Chun-Hui Yang, Li-Min Chen
[ Html ]
[ PDF ] 125-130
doi:10.14218/JCTH.2013.00012
Hepatocellular Carcinoma in Non‐alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention
György Baffy
[ Html ]
[ PDF ] 131-137
doi:10.14218/JCTH.2013.00005
The Effect of Adrenal Replacement Therapy on Rates of Fungal Colonization and Mortality in Critically Ill Patients Awaiting Liver Transplantation
Stephanie G. Yi, Archana R. Sadhu, Stephen L. Jones, Krista Turner, Howard Monsour, Kevin Donahue, Xuefeng Xia, A. Osama Gaber, R. Mark Ghobrial, Sherilyn Gordon Burroughs
doi:10.14218/JCTH.2013.00007
Update on the Development of Anti‐Viral Agents Against Hepatitis C
Kristin L. Macarthur, Robert Smolic, Martina V. Smolic, Catherine H. Wu, George Y. Wu
doi:10.14218/JCTH.2013.007XX
Polymorphism Near the Interleukin‐28B Gene and Anti‐Hepatitis C Viral Response
Yasuhiro Asahina, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe
[ Html ]
[ PDF ] 39-44
doi:10.14218/JCTH.2013.005XX
Genome‐Wide Association Study Reveals Host Genetic Factors for Liver Diseases
Nao Nishida, Katsushi Tokunaga, Masashi Mizokami
[ Html ]
[ PDF ] 45-50
doi:10.14218/JCTH.2013.010XX
The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B
Hong Tang, Jamie Griffin, Steven Innaimo, Lois Lehman-Mckeeman, Cyril Llamoso
[ Html ]
[ PDF ] 51-58
doi:10.14218/JCTH.2013.00006
Drug‐ and Herb‐Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
Rolf Teschke, Axel Eickhoff, Johannes Schulze
[ Html ]
[ PDF ] 59-74
doi:10.14218/JCTH.2013.D002X
The Discovery and Development of Boceprevir: A Novel, First‐generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease
Anita Y. M. Howe, Srikanth Venkatraman
[ Html ]
[ PDF ] 22-32
doi:10.14218/JCTH.2013.002XX